Because of differential expression of thymidine phosphorylase, the active metabolite of capecitabine is thought to localize more readily to tumor cells, reaching local tumor concentrations that are approximately 3-fold higher than in healthy tissue [6–8]. Here, TYMP is linked to neoplasm.